Kim Kelderman

Kim Kelderman serves as the President and CEO of Bio-Techne since May 2018, following the role of President for Diagnostics and Genomics. Kelderman brings extensive experience in the life sciences and clinical diagnostics sectors, having held senior positions at notable companies including Thermo Fisher Scientific, where responsibilities included managing a $1.25 billion Genetic Analysis business. Previous leadership roles also encompassed board membership at Guangzhou Life Technologies DaAn Diagnostics and Kimble Chase Life Science and Research, along with senior operational roles at BD Diagnostics and JOMED Inc. Education includes an Executive course in Strategic Marketing Management from Columbia Business School and studies at Hogeschool Heerlen of Applied Sciences.